Head-to-head comparisons of medication uses, side effects, warnings, and more.
Invokamet (canagliflozin / metformin)
Saxagliptin (Onglyza)
Invokamet (canagliflozin / metformin)
Saxagliptin (Onglyza)
Summary of Invokamet vs. Onglyza
Summary for SGLT2 inhibitor / Biguanide
Prescription only
Invokamet (canagliflozin / metformin) is a combination medication used along with diet and exercise to lower blood sugar levels in adults with Type 2 diabetes. It's available as immediate-release tablets that are taken twice daily, as well as extended-release tablets that are taken once daily. This medication raises the risk of urinary tract infections (UTIs) and genital infections.
Summary for DPP-4 inhibitor
Prescription only
Saxagliptin (Onglyza) is an add-on medication to exercise and a balanced, nutritious diet to improve blood sugar control in adults with Type 2 diabetes. It belongs to the drug class called dipeptidyl peptidase-4 (DPP-4) inhibitors. The saxagliptin (Onglyza) dosage is taken by mouth once daily. Possible side effects include certain infections and headaches. The brand name, Onglyza, is no longer available. But the lower-cost generic version is still available.
Indications of Invokamet vs. Onglyza
Indications for
•Type 2 diabetes
•To lower the risk of major heart events (e.g., heart attack, stroke) in adults with Type 2 diabetes and heart disease
•To lower the risk of hospitalization for heart failure, death due to heart problems, and worsening of kidney problems in certain adults with Type 2 diabetes and diabetic kidney disease
•Available as an extended-release tablet that lasts throughout the day (Invokamet XR)
•Can lower A1C (a blood test that measures your average sugar level over time) by up to 1.8% in people who aren't already taking either Invokana (canagliflozin) or metformin
•Dose can be adjusted based on how well the medication is working for you